retatrutide drops Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. @DrLaPook explains it's doing much more than what current medications can Retatrutide clinical trial done! Now

Dipeptidyl peptidase 4 inhibitor use is associated with a lower risk of incident acute kidney injury in patients with diabetes

In clinical data to date, retatrutide has shown marginally greater weight loss (~24.2% at 48 weeks in Phase 2) compared to Mounjaro (~22.5% at 72 weeks in Phase 3)

Luckily, this sample was benign its basically salty water, he said

How GLP-1 Drugs Can Affect Fertility and Birth Control December 08, 2025 University Hospitals Rainbow Babies & Children's Experts in Children's Health You may have heard stories of surprise Ozempic babies that occur after starting weight loss drugs

Weeks 17 to 20: 5 mg to 2.5 mg weekly